Global Electrophoresis Equipment Market Statistics: USD 2.9 Billion Value by 2032

Summary:

• The global electrophoresis equipment market size reached USD 1.9 Billion in 2023.

• The market is expected to reach USD 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.

• North America leads the market, accounting for the largest electrophoresis equipment market share.

• Vertical electrophoresis holds the biggest market share on account of the increasing demand for user-friendly design that simplifies sample loading.

• Pharmaceutical and biotechnology companies account for the largest market share, driven by the rising focus on drug research and production.

• Technological improvements are making electrophoresis equipment more efficient, accurate, and user-friendly.

• Personalized medicine, which tailors treatment to individual genetic profiles, relies heavily on electrophoresis for biomarker discovery and validation.

Industry Trends and Drivers:

● Integration of Advanced Technologies:

Technological improvements are making electrophoresis equipment more efficient, accurate, and user-friendly. Innovations, such as automated systems, high-throughput capabilities, and enhanced detection methods, benefit in improving the speed and accuracy of biomolecule analysis. These advancements reduce human error, streamline workflows, and increase the capacity for simultaneous analyses, making the technology more appealing to laboratories. In addition, the growing demand for modern electrophoresis systems in research and clinical laboratories due to the rising focus on replacing outdated models is offering a favorable market outlook.

● Rising Prevalence of Chronic Diseases:

The increasing incidence of chronic diseases like cancer, diabetes, and cardiovascular disorders among the masses across the globe is catalyzing the demand for advanced diagnostic tools. Electrophoresis is crucial in diagnosing and monitoring these conditions because it allows for the separation and identification of proteins, deoxyribonucleic acid (DNA), and ribonucleic acid (RNA) in blood and tissue samples. This capability is essential for detecting biomarkers and abnormalities associated with various diseases, facilitating early diagnosis and treatment planning. Furthermore, healthcare providers and diagnostic laboratories require electrophoresis equipment to support the rising number of tests and improve patient outcomes.

● Increasing Demand for Personalized Medicine:

Personalized medicine, which tailors treatment to individual genetic profiles, relies heavily on electrophoresis for biomarker discovery and validation. By enabling precise separation and analysis of genetic material, electrophoresis helps identify specific mutations and biomarkers that can predict a patient’s response to particular therapies. This personalized approach improves treatment efficacy and reduces adverse effects, making it a preferred strategy in modern healthcare. In addition, advancements in genomics and a better understanding of genetic factors in disease are bolstering the market growth.

Request for a sample copy of this report: https://www.imarcgroup.com/electrophoresis-equipment-market/requestsample

Electrophoresis Equipment Market Report Segmentation:

By Product Type:

• Gel Electrophoresis Systems

• Capillary Electrophoresis Systems

• Electrophoresis Accessories

Gel electrophoresis systems represent the largest segment as they are used in a broad range of applications, including the separation and analysis of proteins, DNA, and RNA.

By Type:

• Vertical Electrophoresis

• Horizontal Electrophoresis

Vertical electrophoresis holds the biggest market share on account of the increasing demand for user-friendly design that simplifies sample loading.

By End User:

• Hospitals and Diagnostics Centers

• Academic and Research Institutes

• Pharmaceutical and Biotechnology Companies

• Others

Pharmaceutical and biotechnology companies account for the largest market share, driven by the rising focus on drug research and production.

Regional Insights:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

North America enjoys a leading position in the electrophoresis equipment market, which can be attributed to the presence of well-developed healthcare infrastructure.

Top Electrophoresis Equipment Market Leaders:

The electrophoresis equipment market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Cleaver Scientific Ltd.
• Edvotek Inc.
• Flinn Scientific Inc.
• Hoefer Inc. (Harvard Bioscience Inc.)
• Lonza Group AG
• Lumex Instruments, Merck KGaA
• Nova-Tech International Inc.
• PerkinElmer Inc.
• Qiagen N.V.
• SERVA Electrophoresis GmbH
• Thermo Fisher Scientific Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145